Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530081 | 12653008 | 1 | I | 20160802 | 20160815 | 20160815 | EXP | US-ENDO PHARMACEUTICALS INC-2016-004919 | ENDO | HOFFMANN M, OVERMAN M, NATES J. ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMITANT ORAL OLANZAPINE. THE JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY. 2016 APR;14(4):178-179. | 61.00 | YR | F | Y | 0.00000 | 20160815 | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530081 | 12653008 | 1 | PS | LORAZEPAM TABLETS 1MG | LORAZEPAM | 1 | Oral | 2-3 MG | U | 77754 | 1 | MG | UNKNOWN | ||||||
| 126530081 | 12653008 | 2 | SS | LORAZEPAM TABLETS 1MG | LORAZEPAM | 1 | U | 77754 | |||||||||||
| 126530081 | 12653008 | 3 | SS | LORAZEPAM TABLETS 1MG | LORAZEPAM | 1 | U | 77754 | |||||||||||
| 126530081 | 12653008 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 10 | MG | UNKNOWN | QD | ||||||
| 126530081 | 12653008 | 5 | SS | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | U | 0 | 1 | MG | UNKNOWN | |||||||
| 126530081 | 12653008 | 6 | C | FOLFOX | FLUOROURACILLEUCOVORIN CALCIUMOXALIPLATIN | 1 | Intravenous (not otherwise specified) | FOLINIC ACID, OXALIPLATIN 60 MG/M2 OVER 2 HOURS, FLUOROURACIL 2000 MG/M2 OVER 46 HOURS | 0 | INFUSION | |||||||||
| 126530081 | 12653008 | 7 | C | FOLFOX | FLUOROURACILLEUCOVORIN CALCIUMOXALIPLATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126530081 | 12653008 | 1 | Anxiety |
| 126530081 | 12653008 | 2 | Nausea |
| 126530081 | 12653008 | 3 | Prophylaxis of nausea and vomiting |
| 126530081 | 12653008 | 4 | Prophylaxis of nausea and vomiting |
| 126530081 | 12653008 | 5 | Premedication |
| 126530081 | 12653008 | 6 | Pancreatic carcinoma metastatic |
| 126530081 | 12653008 | 7 | Chemotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126530081 | 12653008 | OT |
| 126530081 | 12653008 | HO |
| 126530081 | 12653008 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126530081 | 12653008 | Drug interaction | |
| 126530081 | 12653008 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |